Rising Pharm`s Generic Methylergonovine Maleate Receives Approval In US
Tulex Pharm's Generic Methylergonovine Maleate Receives Approval in US
Teva Pharms's Generic Methylergonovine Maleate Receives Tentative Approval in US
Amneal Pharms' Generic Methylergonovine Maleate Receives Approval in US
Granules Pharms Generic Methylergonovine Maleate Receives Approval In US
Granules India`s Generic Methylergonovine Maleate Receives Approval In US
Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Methylergonovine Maleate Injection, USP 0.2mg/mL. This product is an AP rated generic to Methergin®, a product owned by Edison Therapeutics, LLC. and is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum hemorrhage. Breckenridge is launching this product in conjunction with the ANDA holder, Ergoject, LLC.
Shares of Lupin were up over 2% at Rs 1,612 on the Bombay Stock Exchange after the company and its US subsidiary, Lupin Pharmaceuticals Inc., announced the re-introduction of Methergine (methylergonovine maleate) Oral tablets 0.2mg in the US.